JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 1, 2007; DOI: 10.1124/jpet.107.130641


0022-3565/08/3242-806-814$20.00
JPET 324:806-814, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.130641v1
324/2/806    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tringham, E. W.
Right arrow Articles by Usowicz, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tringham, E. W.
Right arrow Articles by Usowicz, M. M.

NEUROPHARMACOLOGY

Protease Treatment of Cerebellar Purkinje Cells Renders {omega}-Agatoxin IVA-Sensitive Ca2+ Channels Insensitive to Inhibition by {omega}-Conotoxin GVIA

Elizabeth W. Tringham1, Jonathan R. B. Dupere, C. Elizabeth Payne2, and Maria M. Usowicz

Department of Pharmacology, University of Bristol, Bristol, United Kingdom

The identification of currents carried by N- and P-type Ca2+ channels in the nervous system relies on the use of {omega}-conotoxin (CTx) GVIA and {omega}-agatoxin (Aga) IVA. The peptide {omega}-Aga-IVA inhibits P-type currents at nanomolar concentrations and N-type currents at micromolar concentrations. {omega}-CTx-GVIA blocks N-type currents, but there have been no reports that it can also inhibit P-type currents. To assess the effects of {omega}-CTx-GVIA on P-type channels, we made patch-clamp recordings from the soma of Purkinje cells in cerebellar slices of mature [postnatal days (P) 40–50, P40–50] and immature (P13–20) rats, in which P-type channels carry most of the Ca2+ channel current (≥85%). These showed that micromolar concentrations of {omega}-CTx-GVIA inhibited the current in P40–50 cells (66%, 3 µM; 78%, 10 µM) and in P13–20 Purkinje cells (86%, 3 µM; 89%, 10 µM). The inhibition appeared to be reversible, in contrast to the known irreversible inhibition of N-type current. Exposure of slices from young animals to the enzyme commonly used to dissociate Purkinje cells, protease XXIII, abolished the inhibition by {omega}-CTx-GVIA but not by {omega}-Aga-IVA (84%, 30 nM). Our finding that micromolar concentrations of {omega}-CTx-GVIA inhibit P-type currents suggests that specific block of N-type current requires the use of submicromolar concentrations. The protease-induced removal of block by {omega}-CTx-GVIA but not by {omega}-Aga-IVA indicates a selective proteolytic action at site(s) on P-type channels with which {omega}-CTx-GVIA interacts. It also suggests that Ca2+ channel pharmacology in neurons dissociated using protease may not predict that in neurons not exposed to the enzyme.


Received August 22, 2007; accepted October 31, 2007.

Address correspondence to: Dr. Maria M. Usowicz, Department of Pharmacology, University of Bristol, University Walk, Bristol BS8 1TD, UK. E-mail: m.m.usowicz{at}bris.ac.uk







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.